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The magnitude of a virus-specific CTL response 
is dictated by clonal expansion (van Heijst et al., 
2009), and the number of CTLs at peripheral 
sites of infection can tip the balance in favor of 
viral  clearance  or  persistence.  CTL  numbers 
can also contribute to the severity of immuno-
pathological reactions. Local CTL expansion 
increases the quantity of virus-specific T cells 
needed to offset exponential tissue viral replica-
tion; however, T cell division is thought to be a 
relatively slow process. Naive CD8+ T cells ex-
perience a 27-h lag phase followed by early di-
vision times of 19 h (Veiga-Fernandes et al., 
2000). Even at the peak of the proliferative re-
sponse, CTL division is still estimated to occur 
every 6–8 h in the lymphoid organs (Murali-
Krishna et al., 1998) where APC stimulation 
would theoretically be optimal. With such long 
division times, it is unclear how local peripheral 
responses  out-compete  viral  dissemination. 
Because initial priming of CD8+ T cells with 
antigen  presented  on  MHC  I  and  cytokines 
imparts a differentiation program that dictates 
subsequent division and effector responses, it is 
thought that additional division can occur in the 
absence of further antigen–MHC I interactions 
(Iezzi et al., 1998; van Stipdonk et al., 2001, 
2003; Gett et al., 2003; Mescher et al., 2006; 
Agarwal et al., 2009). Therefore, emigration of 
T cells from lymphoid compartments while still 
in cell cycle may represent a critical mechanism 
that allows immediate turnover and additional 
instruction within peripheral sites of infection.
Another crucial question is whether the CTL 
cell division program can be altered by serial 
interactions received in one or multiple tissues. 
In lymphoid tissues, T cell priming is defined 
by a series of dynamic interactions, some of which 
are transient in nature. For example, CD4+  
T cells initially develop transient interactions 
with the cognate peptide–MHC II–bearing DCs 
that are followed by the formation of long-lived 
T cell clusters where sustained contact is main-
tained for >1 h. By 16–24 h after encounter, T cell 
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After virus infection, cytotoxic T lymphocytes (CTLs) divide rapidly to eradicate the patho-
gen and prevent the establishment of persistence. The magnitude of an antiviral CTL re-
sponse is thought to be controlled by the initiation of a cell cycle program within lymphoid 
tissues. However, it is presently not known whether this division program proceeds during 
migration or is influenced locally at sites of viral infection. We demonstrate that antiviral 
CTLs remain in cell cycle while transiting to infected tissues. Up to one third of virus-
specific CTLs within blood were found to be in cell cycle after infection with lymphocytic 
choriomeningitis virus or vesicular stomatitis virus. Using two-photon microscopy, we found 
that effector CTL divided rapidly upon arrest in the virus-infected central nervous system 
as well as in meningeal blood vessels. We also observed that MHC I–dependent interactions, 
but not costimulation, influenced the division program by advancing effector CTL through 
stages of the cell cycle. These results demonstrate that CTLs are poised to divide in transit 
and that their numbers can be influenced locally at the site of infection through inter-
actions with cells displaying cognate antigen.
This article is distributed under the terms of an Attribution–Noncommercial–Share   
Alike–No Mirror Sites license for the first six months after the publication date 
(see http://www.rupress.org/terms). After six months it is available under a   
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported 
license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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brain tissue (Xu et al., 2007). In this study, we set out to   
address whether CTL division programming is completely 
hardwired (i.e., can occur independent of additional inter-
actions) or can in fact be modulated by peptide–MHC I inter-
actions at sites of viral infection. We demonstrate that CTLs 
remain in cell cycle while transiting through the blood and 
can undergo cytokinesis within 15 min of arrest in the virally 
infected meninges. Importantly, we also show that the CTL 
program is not completely hardwired but is likely cumulative 
and can be modulated by peptide–MHC I–dependent inter-
actions. These results suggest that CTLs integrate signals from 
both lymphoid and nonlymphoid tissues to shape their overall 
proliferative responses.
RESULTS
Virus-specific CTLs migrate in active stages of cell cycle
Initial cognate peptide–MHC I interactions are thought to 
prime CD8+ T cells and generate a cell division program. 
Continued cell cycle progression can then occur in a pep-
tide–MHC I–autonomous manner, with division occurring 
in the absence of further TCR–MHC I interactions (van 
Stipdonk et al., 2001, 2003). CTL programming may there-
fore allow continued cell cycle progression to occur in loca-
tions that are not ideally suited for division as a result of the 
lack of antigen or absence of suitable APCs. During viral in-
fection, there is a large expansion of virus-specific cells that 
occurs within the secondary lymphoid organs (Masopust   
et al., 2007); however, it is unknown whether significant cell 
cycle progression occurs during migration to peripherally 
infected sites. We therefore used the lymphocytic chorio-
meningitis  virus  (LCMV)  model  system  to  determine  if 
CTL cell cycle progression occurs during migration from 
lymphoid organs and locally within infected tissues during 
acute infection.
To study a traceable representative of the CTL response, 
mice were seeded with 104 naive Thy1.1+ P14 CD8+ T cell 
receptor transgenic cells specific for the DbGP33-41 LCMV 
epitope (Pircher et al., 1989) and were then infected intrace-
rebrally (i.c.) with 103 PFU LCMV Armstrong (Arm) to induce 
swarms develop and, >24 h later, examples of division are ob-
served with CD4+ T cells abruptly arresting and undergoing 
cytokinesis within 15 min (Miller et al., 2004). Integration of 
signals  obtained  from  interactions  with  multiple APCs,  or 
successive antigen encounters, was also shown to enhance 
CD4+ T cell differentiation and cytokine production (Gunzer 
et al., 2000; Bajénoff et al., 2002; Faroudi et al., 2003; Celli   
et al., 2005). Although initial priming of CD4+ T cell allows 
division to occur in an antigen-independent manner for 
several rounds of division, proliferation will eventually stop 
and requires further peptide-specific interactions to reinitiate 
the effector CD4+ T cell cycle (Bajénoff et al., 2002). Addi-
tionally, in models of experimental autoimmune encephalo-
myelitis, local CD4+ T cell restimulation in the tissue is required 
to reactivate the cells and generate effector functions (Flügel 
et al., 2001; Kawakami et al., 2004, 2005; Bartholomäus et al., 
2009). Enhanced CD4+ T cell priming and effector function 
is  therefore  reliant  on  numerous  peptide–MHC  II  inter-
actions that are acquired during initial activation and upon entry 
into peripheral tissues. It is presently unknown whether inte-
gration of multiple peptide–MHC I interactions can modu-
late CD8+ T cell division programming during the effector 
stages of an active viral infection. This mechanism would enable 
infected tissues to control CTL numbers locally and thereby 
limit immunopathology.
Control of CTL division is of particular importance in 
the virally infected central nervous system (CNS), an immuno-
logically specialized site (Engelhardt and Ransohoff, 2005) 
which requires the counterbalance of local immunity against 
protection of postmitotic cells such as neurons. During an 
acute viral infection, it is unknown whether CTLs within the 
CNS retain their proliferative capacities and can be influ-
enced by the local milieu. In general, little is known about 
CNS CTL division. Although CNS CD8+ T cell division was 
suggested in vitro and in vivo (Ling et al., 2006, 2008; Wilson   
et al., 2009), it is unclear whether these data represent prolif-
eration before entry into the CNS (i.e., during migration to 
the site), cells that are blocked at early stages of cell cycle, or 
in vitro artifacts caused by responses to mechanical damage in 
Figure 1.  Virus-specific CTLs divide in lymphoid 
and nonlymphoid sites. To determine the cell cycle 
stage of virus-specific CTL, blood (BL), CNS, liver (LIV), 
cervical LNs, and spleen (SPL) of mice seeded with 
Thy1.1+ P14 cells were harvested 15 min after i.p. 
BrdU administration on day 6 after LCMV infection. 
(A) Representative flow cytometric plots of BrdU ver-
sus 7AAD are shown for Thy1.1+ P14 cells extracted 
from tissues of infected mice. (B–E) The ratio of 
Thy1.1+ P14 cells found in G0-G1, S, or G2-M stages 
of cell cycle in the CNS (B), liver (C), LN (D), or spleen 
(E) relative to the blood was calculated for individual 
mice (n = 16–24 mice per group). Data were compiled 
from six independent experiments. The red line is set 
at a ratio of 1 and indicates no difference relative to 
the blood. The ratio of cells in S or G2-M compared 
with G0-G1 was significantly different in all tissues 
examined (P < 0.05, one way ANOVA).JEM VOL. 208, April 11, 2011 
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Ly5.1+ OT-I CTLs isolated from the blood, liver, 
and spleen were found in active stages of cell cycle 
(Fig. S1 A), and the frequency of CTLs in later stages 
of cell cycle (G2-M) was significantly increased   
(P < 0.05) in liver and spleen relative to blood   
(Fig. S1 B). These data indicate that virus-specific CTLs re-
main in cell cycle as they migrate through circulation and are 
therefore poised to complete their cell cycle program upon 
entry into virally infected tissues such as the CNS and liver.
To ensure that we were examining the continuation of the 
effector CTL division program rather than initiation of prim-
ing within these different sites, the activation status of the   
virus-specific CD8+ T cells was examined. Mice seeded with 
naive Thy1.1+ P14 CD8+ T cells were infected i.c. with 103 
PFU LCMV Arm. On day 6 after infection, animals were 
pulsed with BrdU and virus-specific cells isolated from the 
blood, CNS, liver, cervical LNs, and spleen were analyzed for 
CD44, CD62L, and cell cycle progression. Importantly, P14 
cells in all stages of cell cycle were CD44hi, indicating that 
these cells represented an effector population (Fig. 2, A and B). 
Granzyme B staining was performed as another assay to 
ensure that the P14 CTLs under investigation were activated 
effector cells. Virus-specific P14 CTLs extracted from the 
blood, CNS, and spleen on day 6 after infection all expressed 
granzyme B regardless of the cell cycle stage (Fig. 2, C and D). 
These data demonstrate that the CTLs observed cycling in 
blood, lymphoid tissues (spleen and LN), and nonlymphoid 
tissues (CNS and liver) were bona fide effector cells and not 
naive precursors.
CTL division occurs in the CNS and is preceded  
by cellular arrest
To gain novel insights into the anatomy and dynamics of CTL 
division at an active site of viral infection, we focused on the 
LCMV-infected meninges at day 6 after i.c. inoculation. This 
anatomical region was selected for three reasons. First, it re-
mains controversial as to whether CTLs actively divide in 
the CNS. Second, the LCMV-infected meninges contain an 
viral meningitis (Kang and McGavern, 2008). During this 
acute model, CD8+ T cells are primed in peripheral lymphoid 
tissues and then migrate to the CNS on day 6 after infection, 
at which point the mice develop seizure and succumb to dis-
ease (Kang and McGavern, 2008). On day 6 after infection, 
mice were pulsed i.p. for 15 min with BrdU. The short in vivo 
BrdU pulse limited the amount of time peripherally labeled 
CTL had to enter the CNS while still allowing for delinea-
tion of specific cell cycle stages (Dean et al., 1984). After the 
BrdU pulse, mononuclear cells were isolated from the blood, 
perfused CNS, liver, LNs, and spleen. Strikingly, we observed 
by flow cytometry that up to a third of Thy1.1+ P14 CTLs in 
the blood, CNS, and liver were in active stages (S and G2-M) 
of cell cycle (Fig. 1 A) with percentages comparable to those 
observed in the lymphoid organs. The frequencies of cycling 
virus-specific CTL in blood, CNS, and liver are likely even 
higher because the G1 stage cannot be distinguished from G0 
using this methodology. To determine whether the LCMV-
infected nonlymphoid tissues influenced P14 CTL cell cycle 
progression, we calculated frequencies of CTL in all stages of 
cell cycle in the CNS (Fig. 1 B) and liver (Fig. 1 C) relative to 
the blood and compared them to the LNs (Fig. 1 D) and 
spleen (Fig. 1 E) in each individual animal. We noted a statisti-
cally  significant  increase  (P  <  0.05)  in  the  percentage  of 
CNS- and liver-infiltrating P14 CTL in the S and G2-M 
stages of cell cycle, and this trend was comparable to that ob-
served in the LNs and spleen. To demonstrate that our find-
ings were not unique to the LCMV system, we seeded Ly5.1+ 
mice with 104 naive Ly5.2+ OT-I CD8+ T cells and then in-
fected i.v. with 106 PFU of vesicular stomatitis virus (VSV) 
expressing OVA (VSV-OVA) to model a peripheral infection 
(Fig. S1). At day 5 after infection, mice were pulsed with BrdU 
for 15 min. Similar to our previous results, up to a third of 
Figure 2.  Virus-specific CTLs in cell cycle are activated 
effector cells. To determine whether the CD8+ T cells under-
going cell division in the CNS were naive or activated effectors, 
the CNS, liver (LIV), blood (BL), cervical LNs, and spleen (SPL) of 
mice seeded with Thy1.1+ P14 cells were harvested 15 min 
after i.p. BrdU administration on day 6 after LCMV infection. 
(A) Representative flow cytometric plots of CD44 versus CD62L 
for Thy1.1+ P14 cells. Note the absence of naive P14 cells 
(identified as CD62L+ CD44) in the tissues of infected ani-
mals. (B) Quantification of CD44 expression on P14 cells at all 
stages of cell cycle. Data are plotted as mean ± SD and are 
representative of n = 14 mice per group collected over four 
independent experiments. (C) Representative flow cytometric 
plots of granzyme B or isotype control staining versus CD8 for 
Thy1.1+ P14 cells. (D) Granzyme B expression was quantified in 
P14 cells at all stages of cell cycle. Data are plotted as mean ± SD 
and are representative of n = 19 mice per group acquired from 
five independent experiments.750 Cytotoxic T cells divide during migration | Kang et al.
This enabled us to evaluate the position and timing of CTL 
division within the meningeal space. Importantly, this tech-
nique also allowed us to visualize CTL dynamics in the un-
disrupted CNS, thus avoiding potential artifacts induced by 
mechanical tissue damage. We focused exclusively on the final 
phase of cell division (mitosis/cytokinesis) because this could 
be easily observed and quantified. Visual analyses of 4D time 
lapses spanning 30–60 min revealed that 1.4% of P14 CTL 
(11/788 cells) underwent mitosis in the meninges (Fig. 4; and 
Fig. S2, A and B). The cells were normally found beneath the 
skull bone, mostly above the brain parenchyma, and outside 
of meningeal blood vessels (Fig. 4, A and B; and Video 2),   
although division within a blood vessel was observed occa-
sionally (Fig. S2 C; and Video 1, example 3). Quantitative 
analyses of CTL division revealed that mitosis was usually 
preceded by cell arrest, as indicated by low mean track ve-
locities, instantaneous track velocities, and motility coeffi-
cients (Fig. 4, C–E). Dividing CTL did not become fully 
motile again until daughter cells were generated (Fig. 4 E). 
Interestingly, we observed that after deceleration and arrest, 
GFP+ P14 CTL could undergo mitosis within just 10–15 min 
(Fig. S2, A and B; and Video 1, examples 1 and 2). Division 
occurring within minutes of arrest, rather than the estimated 
hours described for naive T cell priming in lymphoid organs 
(Murali-Krishna et al., 1998), supports the idea that many 
CTLs arrive at sites of infection in active stages of cell cycle 
and then receive additional instruction regarding whether to 
divide or not.
Cognate peptide–MHC I interactions 
modify the CTL division program
We have shown previously that direct in-
jection of anti–MHC I into the subarach-
noid space elevates the motility of all GFP+ 
P14 cells in the meninges at day 6 after 
abundance of CTL at this time point, making it convenient to 
study CTL–target cell interactions during a relevant model of 
disease. Third, the meninges can be visualized through a surgi-
cally thinned skull with a two-photon microscope (Kim et al., 
2009; Yang et al., 2010), allowing for real-time analysis of CTL 
division events in a physiological setting. To provide definitive 
evidence of CNS CTL proliferation, we first set out to define 
the anatomical localization of CTL division events. This was 
accomplished using static and dynamic imaging approaches. 
Confocal analyses were performed on 6-µm frozen brain sec-
tions from day-6 mice seeded with GFP-tagged P14 cells 
(McGavern et al., 2002).  Tissues were stained with Ki-67 to mark 
proliferating cells in all stages. Clear examples of Ki-67+ GFP+ 
P14 cells captured during cytokinesis, the last stage of division, 
were detected within the CNS meningeal space (Fig. 3). Quan-
tification of Ki-67+ cells in the meningeal space versus the 
parenchyma revealed that the majority of cycling cells were 
found in the meninges (142/464 cells [30%] in the meninges vs. 
3/85 cells [3.5%] in the parenchyma), suggesting that this 
space is more permissive for T cell division. This is likely a re-
sult of the fact that LCMV infection and infiltrating APCs are 
mostly confined to the meningeal space in this model (Kim 
et  al.,  2009). Together,  these  data  clearly  demonstrate  that 
CTL division can occur within the CNS environment.
To examine the dynamics of CNS CTL division, we per-
formed two-photon laser-scanning microscopy through a thinned 
cranial window (Xu et al., 2007; Yang et al., 2010) in mice at 
day 6 after infection (Fig. 4; Fig. S2; and Videos 1 and 2).   
Figure 3.  Virus-specific CTLs divide in the 
meninges of the CNS. To examine whether virus-
specific CTLs divided locally within the CNS, brains 
from mice seeded with GFP+P14 cells and then 
infected i.c. with 103 PFU LCMV Arm were harvested 
on day 6 after infection. Frozen sections were cut 
and stained with Ki-67 (red) to detect dividing 
CNS-infiltrating GFP+ P14 cells (green). Shown are 
representative panels to reflect anatomical location 
and division events. The top two rows show lower 
magnification images and the dashed lines repre-
sent the border between the meninges and brain 
parenchyma. Bar, 30 µm. The asterisks denote the 
parenchymal portion of the tissue. The white boxes 
in the second row highlight a mitotic CTL that is 
enlarged in the third row. Both the third and fourth 
rows show representative examples of individual 
virus-specific P14 cells undergoing mitosis within 
the meningeal space. Bar, 5 µm. Cell nuclei were 
counterstained with DAPI (blue). Data are represen-
tative of two independent experiments (n = 8 mice).JEM VOL. 208, April 11, 2011 
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compared with microglia as a result 
of their enhanced levels of MHC I and 
costimulatory molecules (Fig. 5 B).   
To determine which CNS APC populations (if any) contained 
LCMV antigen and, thus, the potential to present cognate pep-
tide  to  infiltrating  P14  CTL,  we  generated  a  three-segment 
LCMV  recombinant  that  expresses  teal  fluorescent  protein 
(r3LCMV-TFP) and then flow cytometrically analyzed TFP ex-
pression in CNS cells at day 6 after infection (Fig. S3). Approxi-
mately 1–2% of DCs, macrophages/monocytes, and microglia 
were TFP+ in symptomatic mice at day 6. However, the majority 
of TFP expression was found in stromal cells (CD45.2 gp38+), 
which were demonstrated previously to be a primary target for 
LCMV in the meninges (Kim et al., 2009). Collectively, these 
data demonstrate that multiple meningeal cell populations have 
the potential to be engaged by P14 CTL during meningitis.
Although programming instituted in lymphoid tissues can 
set cell cycle into motion, we postulated that local tissue 
interactions  with APCs  could  further  influence  cell  cycle 
progression. To  determine  whether  CNS APCs  displaying 
cognate peptide–MHC I complexes could impact cell cycle, 
infection, indicating that MHC I interactions influence the 
dynamics of most (if not all) CTLs in the CNS environment 
(Kim et al., 2009). Because our two-photon data revealed that 
P14 CTL division was preceded by cell arrest (Fig. 4, Fig. S2 
B, and Videos 1 and 2), we hypothesized that advancement 
through the division program at sites of infection was depen-
dent in part on cognate peptide–MHC I interactions. To test this 
theory,  we  first  isolated  and  phenotypically  examined  CNS 
APCs at day 6 after infection (Fig. 5, A and B) to determine if 
there were cells that could potentially stimulate virus-specific 
CTL. In both mock and day 6–infected animals, the CD11b+ 
CD45.2lo resident microglia population was detected; how-
ever, infiltrating macrophage/monocytes (CD11b+ CD45.2hi 
CD11c) and DCs (CD11b+ CD45.2hi CD11c+) were only 
detected upon infection (Fig. 5 A). Analysis of surface MHC 
I, MHC II, CD80, and CD86 levels on day 6 after infection 
demonstrated that DCs and macrophage/monocytes recruited 
from  the  periphery  have  a  higher  stimulatory  potential 
Figure 4.  Anatomy and dynamics of 
virus-specific CTL division in the CNS. 
(A) A representative maximal projection of a 
3D z-stack is shown for a mouse at day 6 
after infection. The projection represents 
one time point in a 51-min film. The white 
arrows denote a GFP+ P14 CTL undergoing 
mitosis (See Video 2). The strip beneath the 
maximal projection shows a view through 
z-stack at the position of the dividing cell 
(arrow). Note that the dividing cell is posi-
tioned in the meninges above a blood vessel 
(red) and beneath the skull bone (blue).  
(B) A cropped area is shown depicting the 
dividing CTL in A. Different 3D projections 
were generated by rotating the z-stack 
around the x axis. The dividing CTL is always 
denoted with an arrow. Bars, 20 µm.  
(C) A representative time lapse is shown for 
a P14 CTL (green) dividing in the meninges 
(arrow; see Video 2). The magenta track 
shows the position of the dividing CTL at 
each point in the time lapse. Note that the 
CTL is stationary when compared with three 
motile nondividing CTLs (blue tracks).  
(D) The mean track velocity and motility coef-
ficient were calculated for dividing (red) and 
nondividing (blue) P14 CTLs in the meninges. 
Means are denoted by horizontal bars.  
(E) Instantaneous track velocities are plotted 
versus time for three representative dividing 
(top graph) and nondividing (bottom graph) 
P14 CTLs. Brackets in the top graph denote 
velocities in three phases of CTL division: 
arrest, mitosis, and the split into two 
daughter cells. Data are representative of 
five independent experiments (n = 13 mice).752 Cytotoxic T cells divide during migration | Kang et al.
we harvested cells from the CNS, pulsed them with GP33-41 
peptide, and flow cytometrically sorted microglia, macrophage/
monocytes, and DCs from day 6–infected mice. In parallel, P14 
CTLs were sorted from the spleens of day-6 LCMV Arm– 
infected Thy1.1+P14 seeded animals. The sorted resident and 
infiltrating CNS APCs were then incubated with P14 CTL 
for 1.5 h in vitro, pulsed with BrdU, and the T cells were   
assessed for their BrdU versus 7AAD profile. Interestingly,   
microglia, macrophage/monocytes, and DCs were all able to 
significantly increase (P < 0.001) the frequency of P14 CTL 
in the final G2-M stage of cell cycle (Fig. 5, C and D). More-
over, infiltrating DCs had a slightly higher capacity to advance 
cell cycle progression than tissue-resident microglia (P < 0.05). 
Therefore, both resident and infiltrating CNS APCs have the 
potential to modulate virus-specific effector CTL division 
during viral infection.
To determine whether the modification in cell cycle pro-
gression involved cognate peptide–MHC I interactions, the 
peptide specificity of the response was examined. As a result 
of the inherently difficult nature of isolating sufficient num-
bers of cells from the CNS, splenic DCs were used to stimu-
late P14 CTL. The ability to increase the frequency of CTL 
in G2-M was reproduced using splenic DCs (Fig. 5 E). Sorted 
splenic DCs from LCMV Arm–infected animals were incu-
bated with sorted P14 CTL for 1.5 h in vitro in the presence 
of either GP33-41 peptide or an irrelevant peptide (OVA257-264). 
Interestingly, incubation of P14 CTL (in the presence or ab-
sence of DCs) with GP33-41 peptide significantly increased   
(P < 0.05) the percentage of cells in G2-M (Fig. 5 E). In con-
trast, addition of OVA257-264 had no impact on cell cycle. 
That GP33-41 peptide–pulsed T cells alone showed increased 
frequencies of P14 CTL in G2-M is likely a result of presenta-
tion of peptide by T cell MHC I. These in vitro data indicate 
that cognate peptide–MHC I interactions can influence the 
cell cycle program in virus-specific CTL regardless of whether 
the peptides are displayed on professional APCs or not.
We next sought to determine if local APCs and cognate 
peptide–MHC I interactions influenced the CTL division pro-
gram in vivo. To do this, we first examined the degree to which 
P14 CTL division was associated with engagement of profes-
sional APCs (i.e., DCs) in the CNS. This was accomplished by 
seeding CD11c-YFP reporter mice (Lindquist et al., 2004) 
with CFP+ P14 cells and examining interactions in the me-
ninges by two-photon microscopy at day 6. We observed mul-
tiple examples of P14 CTL clustering around CD11c-YFP+ 
DCs in the meninges and dividing either during or after   
Figure 5.  Peptide–MHC I interactions influence the division pro-
gram of virus-specific CTL. (A) Representative flow cytometric plots 
depict the non–T cell component of CNS mononuclear cells in mock  
versus day-6 LCMV-infected mice. Plots are gated on Thy1.2-negative 
cells. The schematic plot on the far left shows the relative position of 1, 
microglia; 2, neutrophils; and 3, macrophages/monocytes/DCs. To further 
delineate macrophages/monocytes and DCs, the cells in region 3 were 
subdivided into CD11c CD45.2hi CD11b+ (macrophages/monocytes) and 
CD11c+ CD45.2hi CD11b+ (DCs) as shown in the far right plot. Data are 
representative of n = 16–24 mice per group accumulated over four to six 
experiments. (B) Representative histograms show the expression of MHC 
class I (KbDb), MHC class II (I-A/I-E), CD80, and CD86 (red) relative to iso-
type controls (blue) on microglia (Thy1.2 CD45.2lo CD11b+), macro-
phages/monocytes (Thy1.2 CD45.2hi CD11b+ CD11c), and DCs (Thy1.2 
CD45.2hi CD11b+ CD11c+) at day 6 after infection. Data are representative 
of n = 16 mice collected in three separate experiments. (C) Sorted effector 
virus-specific CTL pooled from four mice were stimulated at a 2:1 ratio 
with sorted GP33 peptide-pulsed CNS APCs isolated from day 6–infected 
animals (n = 20). BrdU was added to the in vitro culture for the last  
30 min of the 90-min incubation. Representative BrdU versus 7AAD stain-
ing of CD8+ Thy1.1+ P14 cells incubated alone or with CNS APCs is shown. 
These data are representative of four separate experiments. (D) Normal-
ized percentages of T cells in various stages of cell cycle are shown. Data 
were normalized from four independent experiments. (*, P < 0.05, one-
way ANOVA). (E) Sorted effector Thy1.1+ P14 cells pooled from two to 
four mice were stimulated at a 2:1 ratio with splenic DCs isolated from 
day 6–infected animals (n = 2–3) in the presence of OVA or GP33 peptide. 
The BrdU incubation is the same as in C. Normalized percentages of T cells 
in various stages of cell cycle are shown (*, P < 0.05, one way ANOVA). 
These results are compiled from three independent experiments. Data in  
D and E are plotted as mean ± SD.
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were pulsed with BrdU in vivo for 15 min and 
the perfused CNS was harvested. This short time 
period was used to limit P14 CTL trafficking 
through multiple tissues. Analysis of cell cycle in 
CNS-infiltrating Thy1.1+ P14 CTL revealed that 
H-2Db deletion significantly (P ≤ 0.006) reduced 
the  percentage  of  cells  in  S  phase,  and,  conse-
quently,  increased  the  percentage  of  cells  in 
G0-G1 (Fig. 7, A and B). That we observed an 
increased percentage of CTL in G2-M (rather 
than S) in vitro (Fig. 5, D and E) can be explained by the 
immediate interactions that occur in cultures pulsed with pep-
tide, which likely advance the CTL to a later stage of cell cycle 
in 90 min. During this same time period in vivo, CTL must 
circulate through the blood and extravasate into infected tis-
sues before encountering further peptide–MHC complexes. 
These data indicate that additional MHC I signals received by 
virus-specific CTL support cell cycle progression in vivo.
Because CNS APCs showed increased expression of CD80/
CD86 (Fig. 5 B), and costimulatory molecules can influence 
naive T cell division (Croft et al., 1994; Salomon and Bluestone, 
2001), we examined the influence of these pathways on cell 
cycle by simultaneously blocking CD80 and CD86 with 
CTLA-4-Fc (Linsley et al., 1992; Garidou et al., 2009). 
Thy1.1+P14 seeded animals were infected i.c. with 103 PFU 
LCMV Arm before administration of PBS or CTLA-4-Fc on 
days 4 and 5 after infection. Analysis of BrdU incorporation 
on day 6 after infection revealed that CTLA-4-Fc treatment 
had no impact on cell cycle for P14 CTL found in the CNS 
(Fig. 7 C). To ensure that contributions of the CD80/CD86 
engagement (Fig. 6, A–D; and Video 3). Analysis of P14 CTL 
motility adjacent to meningeal DCs revealed both mobile cells 
(moving at >2 µm/min) and stable cells (moving at ≤2 µm/min; 
Fig. 6, F and G). In general, stable CTLs engaged with DCs 
for longer contact duration times and were statistically more 
likely to divide than motile CTLs (Fig. 6 F). However, CTL 
division was not linked exclusively to DC contact, as exam-
ples of CTL division were observed in areas devoid of CD11c-
YFP+ DCs (Fig. 6 E and Video 3). These data suggest that 
DCs can promote CTL division but are likely not the only 
cell population capable of doing so in the infected meninges.
To evaluate the role of cognate peptide–MHC I inter-
actions in modulating the CTL division program in vivo, Thy1.1+ 
P14 effector cells from day 6–infected spleens (which were all 
CD44hi CD62Llo) were transferred i.v. into either LCMV 
Arm i.c.-infected WT or H-2Db/ Thy1.2+ hosts. DbGP33-41–
restricted P14 CTL transferred into H-2Db/ mice received 
no further peptide–MHC I stimulation; however, meningitis 
proceeded normally in these mice as a result of the intact   
H-2Kb–restricted CTL response. 90 min after transfer, mice 
Figure 6.  CTLs form stable and dynamic contacts 
with DCs during LCMV meningitis. (A–E) Representative 
time lapses of 3D reconstructions show the position of 
dividing CFP+ P14 CTL (green) in relation to CD11c-YFP+ 
DCs (red) in the meninges at day 6 after infection (see 
Video 3). Panel A shows CTL swarming around and contact-
ing a large YFP+ meningeal DC. One P14 CTL (circle) divides 
after contact with this DC. An enlarged view of the divid-
ing cell, as well as the CTL-DC contact point (arrow), is 
shown in B. C and D show two additional examples of CTL 
mitosis after DC contact (arrows), whereas E illustrates a 
P14 CTL that divides when not in contact with a DC. Bars, 
10 µm. (F) Contact durations (in minutes) between P14 CTL 
and meningeal DCs were calculated from 30-min time 
lapses. Contacts were divided into two categories with 
respect to YFP+ DCs: mobile contact (>2 µm/min) and sta-
ble contact (≤2 µm/min). Each dot represents an individual 
P14 CTL. Red dots denote P14 CTL that divided while con-
tacting YFP+ DCs. The mean ± SD contact durations were 
11.0 ± 9.3 min (all), 6.3 ± 5.9 min (mobile), and 17.9 ± 9.3 
min (stable). Asterisk denotes a statistically significant  
(P < 0.00001, Mann-Whitney rank sum test) difference be-
tween mobile and stabile contacts. Means are denoted by 
horizontal bars. (G) The frequency of mobile and stable P14 
CTL contacts represented as a histogram (bin size = 2 min). 
Data are compiled from n = 4 mice (nine different fields).754 Cytotoxic T cells divide during migration | Kang et al.
we conducted a complementary line of investigation that 
involved administration of cognate peptide directly into the 
subarachnoid space (Fig. 8). Mice were seeded with Thy1.1+ 
or GFP+ P14 cells and then infected with LCMV i.c. At day 6 
after infection, a small craniotomy was performed and cognate 
(GP33-41) or an irrelevant (OVA257-264) peptide was adminis-
tered into the subarachnoid space for 90 min. To determine 
the impact on CTL dynamics, we examined the motility of 
GFP+ P14 cells by two-photon microscopy within the first 
hour of peptide administration. As expected, injection of cog-
nate peptide significantly decreased (P < 0.001) both the mean 
velocity and motility coefficient of GFP+ P14 CTL. Within 
costimulation pathways were not being overlooked as a result 
of potential limitations in the ability of the CTLA-4-Fc mole-
cule to cross the blood brain barrier, we also examined an-
other peripheral site of infection (liver). Similar to the brain, 
cell cycle analysis of P14 CTL derived from the liver also 
showed no significant changes in cell cycle upon CTLA-4-Fc 
treatment (unpublished data). Collectively, these data indicate 
that MHC I interactions can directly influence the cell cycle 
program of antiviral CTL in vivo, whereas CD28-dependent 
costimulation is dispensable.
Our  studies  performed  in  H-Db/  mice  support  the 
concept that peptide–MHC I interactions facilitate CTL di-
vision in vivo. To provide additional support for this concept, 
Figure 7.  MHC I but not CD80/CD86 expression influences  
the ability of virus-specific CTL to enter cell cycle in the CNS.  
(A and B) 3.0 × 107 CD8+ T cells isolated from the spleens of day-6 mice 
seeded with Thy1.1+ P14 cells were transferred i.v. into day-6 LCMV- 
infected WT or H-2Db/ recipients. Approximately 2–3 × 106 of the trans-
ferred cells were CD8+ Thy1.1+ P14 cells. 90 min after adoptive transfer, 
recipient mice received 2 mg BrdU i.p. and were harvested 15 min later.  
(A) Representative dot plots of BrdU versus 7AAD staining shown for CD8+ 
Thy1.1+ P14 cells that infiltrated the CNS of recipient mice. (B) The percent-
age of CD8+ Thy1.1+ P14 cells in G0-G1, S, and G2-M is shown for WT or 
H2Db/ mice. Data are shown as mean ± SD for a single experiment and 
are representative of n = 14 mice per group collected over four independent 
experiments. The asterisk denotes statistical significance (P ≤ 0.006,  
Student’s t test). (C) To block CD80 and CD86, WT B6 mice seeded with 
Thy1.1+ P14 cells were injected i.p. on days 4 and 5 after LCMV infection 
with 200 µg CTLA-4-Fc (red) or PBS (black). The percentage of CNS Thy1.1+ 
P14 cells (mean ± SD for a single experiment) in the denoted stages of cell 
cycle was analyzed at day 6 after infection. Data are representative of  
n = 22–24 mice per group acquired over six independent experiments.
Figure 8.  Cognate peptide interactions increase CTL division in the 
meninges. P14 CTL motility and division were examined after administra-
tion of cognate (GP33-41) or irrelevant (OVA257-264) peptide into the sub-
arachnoid space of P14 seeded mice at day 6 after infection. Mean track 
velocities (A) and motility coefficients (B) were calculated for GFP+ P14 
CTL imaged in the meninges within the first hour after peptide adminis-
tration. (*, P < 0.001, Mann-Whitney rank sum test). Each dot represents 
an individual P14 CTL quantified from mice receiving GP33 (n = 1,888 
tracks, n = 11 mice) or OVA (n = 1,016 tracks, n = 8 mice). Data are com-
piled from six to eight independent experiments. Red line denotes the 
mean ± SEM for each group. The normalized frequency (C) and absolute 
number (D) of BrdU+ Thy1.1+ P14 CTL were calculated 90 min after admin-
istration of BrdU and peptide into the subarachnoid space. (*, P < 0.05,  
Student’s t test). Data are plotted as mean ± SEM and are representative 
of 15–16 mice compiled over four independent experiments.JEM VOL. 208, April 11, 2011 
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our two-photon imaging studies verify that the blood is a   
viable site for the continuation of cell cycle. Relative to the 
blood, we also observed an enhanced frequency of CNS and 
liver-infiltrating CTL in the S and G2-M phases of cell cycle, 
which was comparable to that observed in secondary lym-
phoid tissues. These data suggest that CTL can progress through 
cell cycle upon arrival in nonlymphoid sites of viral infection. 
It is important to note that in all of these studies, we pulsed 
animals in vivo for only 15 min with BrdU (an extremely 
limited time frame) to capture events that occurred in the 
tissue under investigation. This enabled us to avoid studying 
CTL division events that transpired in other sites before ar-
rival in the blood or nonlymphoid tissues.
Upon CTL entry into the brain, it is unclear which ana-
tomical regions (if any) fully support CD8+ T cell division. 
In vitro studies have shown that naive OVA-specific CD8+  
T cells could divide after being added to an organotypic brain 
slice culture previously injected with OVA (Ling et al., 2008). 
These data suggest that naive CD8+ T cells might have the 
capacity to be primed and divide in the brain parenchyma 
under more physiological circumstances. However, this con-
clusion was called into question by a more recent study dem-
onstrating that CTL division in brain slices from Toxoplasma 
gondii–infected mice was an extremely rare event and was ob-
served in only 2 of 10,000 cells imaged by two-photon mi-
croscopy (Wilson et al., 2009). In our studies, we used multiple 
approaches to prove that CNS CTL division occurs in vivo 
after an acute viral infection. Our flow cytometric studies dem-
onstrated that one third of CNS-infiltrating P14 CTLs were 
in active stages of cell cycle (S or G2-M). This finding was 
confirmed by confocal microscopic analyses, which revealed 
that 30% of P14 CTLs were Ki-67+ in the meninges, whereas 
only 3.5% were positive in the brain parenchyma. These data 
indicate that the meninges are a more permissive site for CTL 
division in this model system. This is likely a result of the fact 
that viral antigen is restricted primarily to the meninges after 
intracerebral LCMV inoculation; however, it is also conceiv-
able that the brain parenchyma is less permissive of CTL divi-
sion, as suggested in the T. gondii study (Wilson et al., 2009).
Although priming events can impart a differentiation and 
division program in naive T cells that is antigen independent 
(or hardwired), we have demonstrated both in vitro and in 
vivo that the CTL proliferative response can be modulated by 
cognate peptide–MHC I interactions. In fact, one of the most 
interesting findings in our study emerged from videos of P14 
CTL undergoing mitosis/cytokinesis in the virally infected 
meninges. Our results revealed that CTL mitosis was usually 
preceded by cellular arrest and could occur within 15 min of 
this arrest. These data suggested that the CTL division pro-
gram was influenced in part by peptide–MHC I interactions 
and was cumulative in nature. That antiviral CTL can divide 
within 15 min of arrest in the CNS is reminiscent of late-stage 
naive CD4+ T cell priming in the LN (Miller et al., 2004). 24 h 
after first contact with DCs bearing cognate antigen, naive 
CD4 T cells migrate autonomously, eventually stop, round up, 
and undergo mitosis/cytokinesis, all within 20 min (referred 
the meningeal space of mice treated with GP33-41, the majority 
of P14 CTLs were found to be arrested (Fig. 8 A). To determine 
whether enhanced cognate peptide–MHC I interactions influ-
enced CTL division, we administered BrdU into the subarachnoid 
space during the peptide incubation period. The results of this ex-
periment revealed that a short 90-min exposure to GP33-41 peptide 
significantly increased (P = 0.008) both the frequency and abso-
lute number of BrdU+ P14 CTL in the brain (Fig. 8, C and D). 
These data indicate that cognate peptide–MHC I interactions can 
indeed influence CTL division programming.
DISCUSSION
The importance of the T cell division program in determin-
ing the magnitude and efficiency of the antiviral response is 
widely accepted (van Heijst et al., 2009). In this study, we ex-
amined whether the antiviral CTL division program proceeds 
after departure from lymphoid tissues and whether this pro-
gram can be influenced by cognate peptide–MHC I interac-
tions at sites of viral infection. A modifiable, rather than 
completely hardwired, division program would give infected 
tissues the ability to control CTL numbers locally to either 
improve the efficiency of viral clearance or limit unwanted 
immunopathology. Importantly, we observed in two different 
viral model systems that antiviral CTLs circulate through the 
blood in active phases of cell cycle (primarily S phase) and 
could even, on occasion, undergo cytokinesis in meningeal 
vasculature. Within the virus-infected meninges, we definitively 
demonstrated, using two-photon microscopy, that the CNS is a 
permissive site for CTL division. CTL mitosis/cytokinesis is 
normally associated with stable interactions, and division could 
occur within 10–15 min of CTL arrest. Moreover, at the peak 
of  viral  meningitis,  approximately  one  third  of  CTLs  ex-
tracted from the CNS were in active stages of cell cycle, which 
was comparable to what was observed in peripheral tissues 
such as the liver, cervical LNs, and spleen. These data suggest 
that the CTL division program is not completely hardwired 
but rather can proceed in transit and be influenced at sites of 
active viral replication. In support of this concept, we pro-
vided evidence both in vitro and in vivo that peptide–MHC I 
interactions could modulate the CTL division program.
We propose that control of viral dissemination versus pre-
vention of unwanted immunopathology can be balanced in 
part through local modulation of CTL division programming. 
Previous studies have shown that T cell division is a relatively 
slow process that occurs on the order of hours (Murali-Krishna 
et al., 1998; Veiga-Fernandes et al., 2000). In addition, initial 
priming events are thought to impart a cellular division pro-
gram in CD8+ and CD4+ T cells that can later become inde-
pendent of TCR–MHC interactions (van Stipdonk et al., 2001, 
2003; Bajénoff et al., 2002). The initiation of this program in 
secondary lymphoid tissues could explain the relatively high 
frequency of CTL we observed cycling in the blood. In fact, 
20% of P14 CTLs in the blood were found in S phase, indi-
cating that division is not accomplished solely in solid lym-
phoid and nonlymphoid tissues but can occur during T cell 
migration throughout the body. These data combined with 756 Cytotoxic T cells divide during migration | Kang et al.
meningeal CD11c+ DCs and that division could occur either 
during or after DC engagement. This observation is consis-
tent with a recent study showing that DCs can support 
memory CD8 T cell division in sensory dorsal root ganglia 
latently infected with herpes simplex virus (Wakim et al., 
2008). However, CTL division in the LCMV-infected me-
ninges was not linked exclusively to DC contact, as mitotic 
events were observed in areas devoid of DCs. Thus, although 
it is clear from our studies that CTL division can be linked to 
DC contact, it will be important in future studies to identify 
the other cell populations and molecular mediators that 
support CTL division in the brain. It will also be important 
to define the factors that dictate whether a CTL divides or 
kills after target cell engagement.
In conclusion, our novel findings demonstrate that the 
division program is not completely hardwired and destined to 
occur exclusively in lymphoid tissues. Rather, antiviral CTLs 
remain in cell cycle during migration through the blood and 
can undergo mitosis within 15 min of arrest in a virally in-
fected tissue. These data suggest that the division program is 
cumulative and results from the summation of signals received 
systemically after infection. Departure of CTL from lymphoid 
tissues while in cell cycle likely gives the host an advantage 
over the invading pathogen by allowing the response to be 
modulated as needed at the site of infection. We postulate that 
this mechanism enables infected tissues to fine-tune the adap-
tive immune response by applying proliferative brakes to limit 
unwanted immunopathology or by facilitating cell cycle pro-
gression to outcompete increasing viral replication. The latter 
is important from the standpoint of viral control, as it was re-
cently shown that effector/target cell ratios at the site of in-
fection correlate with whether a pathogen is controlled or not 
(Li et al., 2009). Our data demonstrate that CTL division can 
be influenced by cognate peptide–MHC I interactions; how-
ever, the degree to which the division program is aborted 
versus enhanced at the site of infection remains to be deter-
mined. If both positive and negative signals can be imposed 
on the division program locally, then it should be possible to 
therapeutically modulate CTL at sites of infection to foster 
clearance while preserving tissue integrity.
MATERIALS AND METHODS
Mice.  C57BL/6J  (B6),  B6.SJL-Ptprca  Pepcb/BoyJ  (Ly5.1  mice),  BL/6-
Tg(TcraTcrb)1100Mjb/J  (OT-I  mice),  B6 Thy1.1+DbGP33–41 TCR-tg 
(Thy1.1 P14), B6 GFP+DbGP33–41 TCR-tg (GFP P14), B6 CFP+DbGP33–41 
TCR-tg (CFP P14), B6 H-2Db/, and B6 CD11c-YFP mice were bred and 
maintained in closed facilities at the National Institutes of Health, The Scripps 
Research Institute, and New  York University. B6, Ly5.1, and OT-I mice were 
originally purchased from The Jackson Laboratory. CD11c-YFP mice (gift 
from M. Nussenzweig, Rockefeller University, New York, NY; Lindquist   
et al., 2004) were backcrossed for three additional generations to obtain mice 
on a pure C57BL/6J background. After backcrossing, the mice were con-
firmed to be C57BL/6J by SNP analysis (Taconic). All mice were handled in 
accordance with the guidelines set forth by the National Institutes of Health 
Animal Care and Use Committee.
Viruses. Animals were infected i.c. with 103 PFU LCMV Arm clone 53b   
or i.v. with 106 PFU VSV-OVA (gift from L. Lefrancois, University of Con-
necticut Health Center, Farmington, CT; Vezys et al., 2000). A three-segment 
to as stage V; Miller et al., 2004). Our CTL imaging data sug-
gest that effector cells have the capacity to depart lymphoid 
tissues during this stage and complete their division program 
elsewhere. This supposition is consistent with the ability of   
T cells to integrate signals through multiple transient inter-
actions. In fact, it is well described that CD4+ T cells during 
priming can accumulate signals after interactions with differ-
ent APCs that allow for differentiation and proliferation 
(Gunzer et al., 2000; Faroudi et al., 2003; Celli et al., 2005).   
In vitro, T cells exposed to intermittent signaling were still 
able to generate IFN- responses, indicating that signals can 
be  integrated  over  time. Additionally,  although  hardwired 
programming was sufficient for the first few rounds of CD4+ 
T cell division, secondary waves of proliferation were depen-
dent on reexposure to antigen (Bajénoff et al., 2002).
We previously demonstrated in the LCMV meningitis 
model that injection of anti–MHC I antibody into the sub-
arachnoid space shifts the velocity distribution for the entire 
population of meningeal P14 CTL (Kim et al., 2009), sug-
gesting that all P14 cells encountered antigen during the imag-
ing period. Because CTL arrested before undergoing mitosis, 
we hypothesized that this event might also be linked to cognate 
peptide–MHC I engagement. This conclusion is supported 
by our in vitro studies showing that cognate peptide–MHC 
(but  not  irrelevant  peptide–MHC)  interactions  modulate 
CTL cell cycle progression. We also demonstrated in vivo that 
the absence of MHC I interactions significantly reduced the 
percentage of CTL in S phase, whereas direct injection of 
cognate peptide into the subarachnoid space increased the 
frequency and absolute number of BrdU+ CTL in the brain. 
Although peptide–MHC I peptide interactions were impor-
tant for the enhancement (or maintenance) CTL cell cycle 
programming, CD28-dependent costimulation was dispens-
able. Simultaneous blockade of CD80 and CD86 had no   
impact on CTL cell cycle programming in vivo. Collectively, 
these data suggest that after departure from lymphoid tissues 
CTLs continue to integrate proliferative signals obtained from 
nonlymphoid sites of infection (in this case, the CNS). It is 
also plausible that serial transient interactions at the site of 
infection contribute to the overall proliferative program. Pro-
gramming acquired through transient contacts would be consis-
tent with the fact that most P14 CTLs in the LCMV-infected 
meninges do not engage in stable long-duration interactions 
(Kim et al., 2009), as well as with a recent study demonstrat-
ing that T cell receptor internalization is not completely de-
pendent on motility arrest or stable immunological synapse 
formation (Friedman et al., 2010).
Based on our in vitro and in vivo data, the cell populations 
that support CTL division in the meninges likely include 
both professional and nonprofessional APCs. Microglia, mac-
rophages, DCs, and stroma were all found to contain LCMV 
antigen and, thus, had the opportunity to present peptide–
MHC I complexes to P14 CTL. Moreover, our in vitro stud-
ies demonstrated that display of cognate peptide–MHC I by 
professional APCs or T cells similarly advanced the CTL divi-
sion program. In vivo, we observed that CTL clustered around JEM VOL. 208, April 11, 2011 
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which peptide was injected into the subarachnoid space, Thy1.1+ P14 seeded 
animals were infected with 103 PFU LCMV Arm. On day 6 after infection, 
animals were anaesthetized and 10 mg/ml BrdU was mixed with 0.17 mg/ml 
GP33-41 or OVA257-264 peptide was administered into the subarachnoid space 
of the brain through a small open skull preparation and incubated for 30 min. 
10 mg/ml BrdU alone was then incubated for another hour before saline 
perfusion and isolation of Thy1.1 P14 cells from the brain for analysis of 
BrdU incorporation by flow cytometry.
In vitro BrdU studies. Splenocytes of 104 Thy1.1+ P14 seeded animals were 
harvested on day 6 after i.c. infection with 103 PFU LCMV Arm. Cells were 
stained with anti-Thy1.1 PE (BD), CD8 APC-Cy7 (BioLegend), and 7AAD 
(BD) in 2% FBS/PBS for 20 min on ice. Virus-specific T cells were sorted 
for Thy1.1+ CD8+ 7AAD cells to a purity of >95%. To generate CNS APCs, 
the microglia and mononuclear infiltrates in brains from PBS perfused day-6 i.c 
LCMV-infected C57BL/6 animals were isolated and pulsed with 1 µg/ml 
GP33-41 peptide in RPMI complete (10% FBS, 10 U/ml penicillin, 10 µg/ml 
streptomycin, 2 mM glutamine, and 50 uM -mercaptoethanol; Invitrogen) for 
1 h at 37°C. Cells were washed and stained with anti-Thy1.2 APC (Bio-
Legend), CD11b PE/Cy7 (eBioscience), CD11c APC/Cy7 (BioLegend), and 
CD45.2 FITC and 7AAD (BD) in 2% FBS/PBS for 20 min on ice. Thy1.2 
7AAD cells were sorted into three groups: microglia (CD45lo CD11b+), mac-
rophage/monocytes (CD45hi CD11b+ CD11c), and DCs (CD45hi CD11b+ 
CD11c+). All cells were sorted on a FACSAria Digital Cell Sorter (BD). Splenic 
DCs obtained from day-6 i.c. LCMV-infected C57BL/6 animals were stained 
and sorted by the same criteria as CNS DCs. Thy1.1+ P14 cells were plated 
with sorted CNS APCs at a ratio of 2:1, centrifuged for 5 min to increase cell–
cell interactions, and incubated for 90 min at 37°C at 5% humidity. For in vitro 
stimulation, splenic DCs were plated at the same T cell/DC ratio and 1 µg/ml 
peptide, either OVA257-264 (SIINFEKL) or GP33-41 (KAVYNFATC), was added 
to the wells for the duration of the 90-min incubation. During the last 30 min 
of culture, cells were pulsed with 10 µM BrdU. Cultures were harvested, Fc 
blocked for 15 min on ice, surface stained with anti-Thy1.1 PE (BD) and CD8 
Pacific blue (Caltag) for 20 min on ice, and analyzed for cell cycle according to 
the BrdU APC flow kit manufacturer’s instructions (BD). Normalized cell   
cycle percentages in Fig. 5 (D and E) were calculated by dividing individual 
percentages by the highest value in the group for that experiment.
Thy1.1+ P14 transfers into H-2Db/ mice. CD8+ T cells were purified 
from mice seeded with 104 Thy1.1+ P14 cells on day 6 after i.c. infection   
using CD8+ beads (Miltenyi Biotec). 20–30 × 106 CD8+ T cells (2.5–3 × 106 
Thy1.1+ P14 CTL) were injected retroorbitally into C57BL/6 or H-2Db/ 
mice at day 6–6.5 after infection with 103 PFU LCMV Arm i.c. 90 min after 
T cell transfer, animals were injected with 2 mg BrdU i.p. for 15 min, PBS 
perfused, and the brains were harvested. Cells were stained as indicated in the 
in vivo BrdU portion of the methods section.
Immunohistochemistry. To  examine  virus-specific  CTL  cell  division, 
brains from 104 P14 GFP+ seeded mice were perfused with 4% PFA (Sigma-
Aldrich) on day 6 after infection with 103 PFU LCMV Arm i.c. Brains were 
frozen in O.C.T. (VWR) after an overnight incubation in 4% PFA followed 
by an overnight incubation in 30% sucrose (Thermo Fisher Scientific). 6-µm 
frozen sections were cut, fixed with 4% paraformaldehyde for 15 min, blocked 
with an avidin/biotin-blocking kit (Vector Laboratories), and stained at 4°C 
overnight with primary rabbit antibodies against Ki-67 (1:50; Leica). The 
primary antibody was detected with donkey anti–rabbit rhodamine red-X 
for 1 h at room temperature (1:200; Jackson ImmunoResearch Laboratories, 
Inc.). Sections were further stained with 1 µg/ml DAPI (Sigma-Aldrich) for 
3 min at room temperature to visualize cell nuclei. All working stocks of pri-
mary and secondary reagents were diluted in PBS containing 2% FBS.
Confocal microscopy. 2D colocalization images to analyze Ki-67 staining 
in GFP+ P14 CTL were captured from 6-µm frozen brain sections using a 
MRC2100 confocal microscope (Bio-Rad Laboratories) fitted with 40, 63, 
and 100× oil objectives and seven laser lines that excite at 405, 457, 477, 488, 
514, 543, and 637 nm (Carl Zeiss).
recombinant of LCMV expressing TFP was generated as described previ-
ously  (r3LCMV-TFP;  Emonet  et  al.,  2009).  In  brief,  we  generated  an 
LCMV recombinant containing one L and two S segments. The entire 708-bp 
coding region for TFP (Allele Biotech) was PCR amplified using primers 
(5-GAGCAACAAGGTGTCTTCTAGTATGGTGAGCAAGGGCGA-
GGAG-3  and  5-AGGGTCTTGTCTTCTCACAACATTTGGGCC-
TCTAAAAATTAGGTCATGTGGCAGAATGTTGGCTAGCAGGCC-
TTCACTTGTACAGCTCGTCCATG-3) containing BbsI sites and sub-
sequently cloned into a vector containing the LCMV S genomic segment   
backbone (pol-I GPC/BbsI; Emonet et al., 2009). r3LCMV-TFP was then 
rescued by transfecting 70% confluent BHK-21 cells with five plasmids (0.8 µg 
pC-NP, 1.0 µg pC-L, 1.4 µg pol-I L, 0.8 µg pol-I BsmBI/NP, and 0.8 µg 
pol-I GPC/TFP) using Lipofectamine-2000 (Invitrogen). At 72 h after transfec-
tion, the cell culture supernatant was passed to a fresh cell monolayer to 
isolate LCMV-TFP by plaque purification. The virus isolates were further 
passaged five times in BHK-21 cells, after which viral stocks were generated 
for subsequent animal experiments. Because three segment LCMV recombi-
nants are attenuated compared with WT virus (Emonet et al., 2009), we 
infected mice i.c. with 106 PFU r3LCMV-TFP to induce meningitis with 
normal disease kinetics.
Mononuclear cell isolations. To obtain cell suspensions for flow cytomet-
ric analysis and sorting, brains were harvested from mice after an intracardiac 
perfusion with 20 ml of 0.9% saline solution to remove the contaminating 
blood lymphocytes. The CNS was incubated with 1 ml collagenase D (1 mg/ml; 
Roche) at 37°C for 30 min. Single-cell suspensions were prepared by me-
chanical disruption through a 100-µm filter. Brain-infiltrating leukocytes 
were isolated and counted as described previously (Lauterbach et al., 2006).
Flow cytometry. Leukocytes harvested from the brain, blood, cervical LNs, 
and  spleen  were  blocked  with  3.3  µg/ml  anti–mouse  CD16/CD32  (Fc 
Block; BD) in PBS containing 1% FBS and 0.1% sodium azide for 10 min on 
ice. Cells were surfaced stained with a combination of the following conju-
gated antibodies: CD45.2 FITC (104), CD11c PE (HL3), Thy1.1 PE (Ox-7), 
Thy1.2 PE (53–2.1; BD), gp38 PE (8.1.1), CD80 PerCP Cy5.5 (16-10A1), 
IA/IE PerCP Cy5.5 (M5/114.15.2), CD86 APC (GL-1), H2 KbDb FITC 
(28–8-6), CD11c Pacific Blue (N418), CD45.2 Alexa Fluor 700 (104; Bio-
Legend), CD8 Pacific Blue (Invitrogen), CD44 FITC (IM7), CD62L PECy7 
(MEL-14), and anti-CD11b PE/Cy7 (M1/70; eBioscience) for 20 min on 
ice. Cell cycle staining was conducted according to manufacturer’s instruc-
tions using the BrdU APC cell cycle analysis kit (BD). In some cases, PE-
conjugated antibodies against granzyme B (GB11) or an isotype control 
(Invitrogen) were added at the same time as the BrdU APC staining to exam-
ine granzyme expression during cell cycle. Cells were acquired using a digital 
flow cytometer (Digital LSR II; BD) and flow cytometric data were analyzed 
with FlowJo software (Tree Star, Inc).
CD8+ T cell isolations. CD8+ T cells were purified from Thy1.1+ P14, 
GFP+ P14, CFP+ P14, or Ly5.2+ OT-I mouse splenocytes by negative selec-
tion (STEMCELL Technologies). The purity after enrichment was deter-
mined to be >98%. For imaging and flow cytometric studies, 104 purified 
naive P14 or OT-I T cells were injected i.v. into naive mice. Mice were sub-
sequently challenged with LCMV Arm or VSV-OVA.
In vivo BrdU studies. Animals were seeded with 104 Thy1.1+ P14 cells   
before i.c. infection with 103 PFU LCMV Arm or 104 Ly5.2+ OT-I cells be-
fore i.v. infection with 106 PFU VSV-OVA. On day 6 after LCMV infection, 
animals were injected i.p. with 2 mg BrdU (Sigma-Aldrich) for 15 min.   
VSA-OVA–infected mice were injected with BrdU at day 5 after infection. 
Blood was collected from animals before perfusion with 20 ml saline. The brain, 
spleen, liver, and cervical LNs were harvested and single cell suspensions were 
generated from all of these organs. Cells were surfaced stained with antibod-
ies to detect Thy1.1+ P14 or Ly5.2+ OT-I CD8 T cells and then further fixed, 
permeabilized, and stained for BrdU and 7AAD according to the BrdU APC 
flow cytometry kit manufacturer’s instructions (BD). For BrdU studies in 758 Cytotoxic T cells divide during migration | Kang et al.
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